Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: A systematic review and meta-analysis

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Liu, Kai xiong ^a   Zhu, Ying gang ^a   Zhang, Jing ^a   Tao, Li li ^a   Lee, Jae Woo ^b   Wang, Xiao dan ^a   Qu, Jie ming ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL CRAMP; ANTIMICROBIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CRITICALLY ILL PATIENT; DIARRHEA; DRUG EFFECT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTESTINE ISCHEMIA; META ANALYSIS; MORBIDITY; MORTALITY; NOSOCOMIAL PNEUMONIA; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; CRITICAL ILLNESS; CROSS INFECTION; DIET THERAPY; PNEUMONIA, VENTILATOR-ASSOCIATED; PROCEDURES;

CRITICAL ILLNESS; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84862617679     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11398     Document Type: Article

References (38)

1. Kollef MH. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004, 32:1396-1405. 10.1097/01.CCM.0000128569.09113.FB, 15187525.
2. American Thoracic Society and Infections Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated pneumonia, and healthcare associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. American Thoracic Society and Infections Diseases Society of America.
3. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005, 33:2184-2193. 10.1097/01.CCM.0000181731.53912.D9, 16215368.
4. Estes RJ, Meduri GU. The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonisation and airway inoculation. Intensive Care Med 1995, 21:365-383. 10.1007/BF01705418, 7650262.
5. Oostdijk EA, de Smet AM, Blok HE, Thieme Groen ES, van Asselt GJ, Benus RF, Bernards SA, Frenay IH, Jansz AR, de Jongh BM, Kaan JA, Leverstein-van Hall MA, Mascini EM, Pauw W, Sturm PD, Thijsen SF, Kluytmans JA, Bonten MJ. Ecological effects of selective decontamination on resistant Gram-negative bacterial colonization. Am J Respir Crit Care Med 2010, 181:452-457. 10.1164/rccm.200908-1210OC, 19965807.
6. Oudhuis GJ, Bergmans DC, Dormans T, Zwaveling J-H, Kessels A, Prins MH, Stobberingh EE, Verbon A. Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med 2011, 37:110-117. 10.1007/s00134-010-2002-6, 3020315, 20721536.
7. Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers GT. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr 2010, 140:698S-712S. 10.3945/jn.109.113753, 20107143.
8. Schultz MJ, Haas LE. Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review. Critical Care 2011, 15:R18. 10.1186/cc9963, 3222052, 21232110.
9. Isakow W, Morrow LE, Kollef. Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest 2007, 132:286-294. 10.1378/chest.06-2156, 17625089.
10. McNabb B, Isakow W. Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opin Pulm Med 2008, 14:168-175. 10.1097/MCP.0b013e3282f76443, 18427239.
11. Joint FAO/WHO working group. Guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food 2002, London, Ontario, Canada.
12. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis 2002, 46(Suppl 2):S87-S91.
13. Forsythe P. Probiotics and lung diseases. Chest 2011, 139(4):901-908. 10.1378/chest.10-1861, 21467057.
14. Isolauri E, Sutas Y, Kanaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001, 73:444S-450S.
15. Alberda C, Gramlich L, Meddings J, Field C, McCargar L, Kutsogiannis D, Fedorak R, Madsen K. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007, 85:816-823.
16. Van Minnen LP, Timmerman HM, Lutgendorff F, Verheem A, Harmsen W, Konstantinov SR, Smidt H, Visser MR, Rijkers GT, Gooszen HG, Akkermans LM. Modification of intestinal flora with multispecies probiotics reduce bacterial translocation and improve clinical course in rat model of acute pancreatitis. Surgery 2006, 141:470-480.
17. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121:580-591. 10.1053/gast.2001.27224, 11522742.
18. Ewaschuk J, Endersby R, Thiel D, Diaz H, Backer J, Ma M, Churchill T, Madsen K. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 2007, 46:841-850. 10.1002/hep.21750, 17659579.
19. Zhou HJ, Yin L, Chen CQ, Shi MM, Zhang MJ. Administration of probiotics reduces bacterial translocation after intestinal transplantation in rats. Transplantation Proceedings 2010, 42:4643-4647. 10.1016/j.transproceed.2010.09.171, 21168752.
20. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 2006, 30:1848-1855. 10.1007/s00268-005-0653-1, 16983476.
21. Klarin B, Molin G, Jeppson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomized controlled open pilot study. Crit Care 2008, 12:R136. 10.1186/cc7109, 2646346, 18990201.
22. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010, 182:1058-1064. 10.1164/rccm.200912-1853OC, 2970846, 20522788.
23. Giamarellos-Bourboulis EJ, Bengmark S, Kannellakopoulou K, Kotzampassi K. Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 2009, 67:815-821. 10.1097/TA.0b013e31819d979e, 19820590.
24. Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005, 390:104-113. 10.1007/s00423-004-0536-1, 15711820.
25. Rayes N, Hansen S, Seehofer D, Muller AR, Serke S, Bengmark S, Neuhaus P. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002, 18:609-615. 10.1016/S0899-9007(02)00811-0, 12093440.
26. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation: a randomized, double-blind trial. Am J Transplant 2005, 5:125-130. 10.1111/j.1600-6143.2004.00649.x, 15636620.
27. Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nüssler NC, Bengmark S, Neuhaus P. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy. Ann Surg 2007, 246:36-40. 10.1097/01.sla.0000259442.78947.19, 1899208, 17592288.
28. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 2007, 31:119-126.
29. Tan M, Zhu JC, Du J, Zhang LM, Yin HH. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Critical Care 2011, 15:R290. 10.1186/cc10579, 3388628, 22136422.
30. Barraud D, Blard C, Hein F, Marçon O, Cravoisy A, Nace L, Alla F, Bollaert PE, Gibot S. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010, 36:1540-1547. 10.1007/s00134-010-1927-0, 20502866.
31. Forestier C, Guelon D, Cluytens V, Guillart T, Sirot J, De champs C. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebocontrolled pilot study in intensive care unit patients. Crit Care 2008, 12:R69. 10.1186/cc6907, 2481460, 18489775.
32. Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009, 35:854-861. 10.1007/s00134-008-1368-1, 19083199.
33. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG, . Dutch Acute Pancreatitis Study Group Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371:651-659. 10.1016/S0140-6736(08)60207-X, 18279948, Dutch Acute Pancreatitis Study Group.
34. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
35. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 2010, 38:954-962. 10.1097/CCM.0b013e3181c8fe4b, 20016381.
36. Pitsouni E, Alexious V, Saridakis V, Peppas G, Falagas ME. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Pharmacol 2009, 65:561-570.
37. Watkinson PJ, Barber VS, Dark P, Young JD. The use of pre-pro- and synbiotics in adult intensive care unit patients: systemic review. Clin Nutr 2007, 26:82-192.
38. Sun S, Yang K, He X, Tian J, Ma B, Jiang L. Probiotics in patients with severe acute pancreatitis: a meta-analysis. Langenbecks Arch Surg 2008, 394:171-177.